Jonathan Carlson
Founder and Principal
JFCadvisory
If you’re a visionary leader at a growth stage biopharma company, I help you identify a calculated and informed path to scale — one that mitigates risk, maximizes value, and capitalizes on your existing successes.
My frameworks provide a proven path to sustainable growth and enhanced enterprise value by overcoming common challenges, such as:
-Revenue plateaus
-Operational disruption
-Risk exposure
This stops leaders of biopharma companies from achieving:
-Sustainable growth
-Operational scalability
-Proper risk identification and management
📈 HOW I GET RESULTS FOR MY CLIENTS
As a trusted Business Advisor with decades of experience in the life sciences sector, I help small to midsize Biopharma companies achieve sustainable growth, accelerate time to market, and mitigate risks - allowing industry leaders to put their stamp on their company’s future!
→ Maximize the value of your acquisition or strategic alliance, expedite functional due diligence and time to close, and integrate seamlessly.
→ Accelerate time to market and maximize your enterprise value.
→ Mitigate risk and limit exposure that is inevitable in the growth lifecycle of your company.
✅ WHO I WORK WITH
Founders and Executives of growth stage Biopharma companies who are:
-Balancing aggressive growth targets and practicalities of limited resources
-Looking to maximize the value of a strategic acquisition or industry alliance
-Concerned about potential operational risks through the growth lifecycle
-Working to improve enterprise value to attract further investment
Vincent Cafiso
Founder, Managing Consultant
Practical Compliance Results LLC »
As a former FDA Investigator with 30-years of industry expertise, I prepare medical device and IVD companies to be ready for their next FDA inspection and Notified Body audit in the areas of compliance and quality.
- 30 years of experience in the creation, maintenance, remediation, and auditing of quality system and technical documentation for sterile and non-sterile medical device and in vitro diagnostics (IVD) companies from startup stage to fully commercial to ensure compliance with domestic and international quality and regulatory requirements.
- Support my clients by providing expertise in building, training, leading, and motivating high-functioning quality and regulatory compliance teams ensuring lasting knowledge transfer and inspection readiness.
- Talented internal and supplier auditor having practical experience with FDA inspection techniques, Quality System Regulation (QSR and QMSR), and on-site inspection procedures.
- Proficient in European and Global quality system standards such as ISO 13485, ISO 14971, ISO 9001, and the EU Medical Device Regulations (MD/AIMD, IVD) and associated Technical Documentation.
- Work extensively with contract design and manufacturing organizations (CDMO) to ensure that product is designed and manufactured in compliance with client, US, and international quality system requirements.
- FDA-483, Warning Letter, and Consent Decree responses and overall compliance.
Areas of Expertise:
FDA Regulations / QSR / QMSR
ISO 13485 Quality Management Systems
FDA Inspection Procedures
Quality System Inspection Technique (QSIT)
Quality Assurance
Quality Systems
Quality Control
Regulatory Compliance
Change Control
Culture Change
FDA Readiness and Remediation
Recall / Field Action
Complaint Handling
Internal, Supplier, Third Party Audits
Inspection and Testing
Process Control
Control of Nonconforming Product
Corrective Action (CA)
Preventive Action (PA)
Qualification and Validation
Design Control
Management Review
Project Management
Clinical Trials
Sterilization
Product Stability
Calibration
Preventative Maintenance
ISO 14971 Risk Management
ISO 9001 Quality Management Systems
ISO 19011 Audit Management
AIMD / MD / IVD / Biotechnology
Start-up companies
Class I, II, III Medical Devices
Expert Witness
Alice Bonnen
Partner
Myers Bigel, P.A. »
Patent counseling, preparation and prosecution in life sciences and agricultural biotechnology including expertise in procuring plant patents and plant variety protection; patentability, validity, freedom to operate, infringement analyses.
Pagination
- Previous page
- Page 4